We are live on !
Find out more
Robert Torray Torray Investment Partners
AUM
$741M
Turnover
9.57%
1-Year Est. Return
26.16%
Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.
This Fund
S&P 500
This Quarter Est. Return
+0.47%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.58%
AUM
$1.1B
AUM Growth
+$114M
(+12%)
Cap. Flow
+$121M
Cap. Flow % of AUM
Cap. Flow %
10.97%
Top 10 Holdings %
Top 10 Hldgs %
27.69%
Holding
94
New
3
Increased
32
Reduced
7
Closed
6
Avg Time Held
1
year
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$19.4M |
| 2 |
Blackrock
BLK
|
+$18.6M |
| 3 |
Verisk Analytics
VRSK
|
+$15M |
| 4 |
Baxter International
BAX
|
+$7.37M |
| 5 |
RTX Corp
RTX
|
+$6.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin Templeton
BEN
|
+$20M |
| 2 |
MCRS
MICROS SYSTEMS INC
MCRS
|
+$15.7M |
| 3 |
Republic Services
RSG
|
+$3.16M |
| 4 |
Intel
INTC
|
+$2.82M |
| 5 |
Marsh
MRSH
|
+$2.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.85% |
| 2 | Healthcare | 19% |
| 3 | Industrials | 13.74% |
| 4 | Financials | 11.57% |
| 5 | Energy | 9.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Baxter International
BAX
$12.9B
| $38.2M | 3.46% |
978,615
+181,569
| +23% | +$7.37M |
2013 Q2
5 quarters
|
|
2
Apple
AAPL
$4.99T
| $32.4M | 2.94% |
1,284,548
+149,612
| +13% | +$3.67M |
2013 Q2
5 quarters
|
|
3
Fiserv Inc
FISV
$25.2B
| $31.2M | 2.83% |
966,126
+146,580
| +18% | +$4.63M |
2013 Q2
5 quarters
|
|
4
Danaher
DHR
$158B
| $30.9M | 2.81% |
605,545
+115,902
| +24% | +$5.96M |
2013 Q2
5 quarters
|
|
5
Visa
V
$756B
| $30.7M | 2.79% |
576,116
+94,300
| +20% | +$5.07M |
2013 Q2
5 quarters
|
|
6
Enbridge
ENB
$105B
| $29.7M | 2.7% |
620,990
+95,990
| +18% | +$4.74M |
2013 Q2
5 quarters
|
|
|
7
RTX Corp
RTX
$260B
| $29.1M | 2.64% |
437,536
+96,150
| +28% | +$6.59M |
2013 Q2
5 quarters
|
|
8
VF Corp
VFC
$6.72B
| $28.4M | 2.58% |
456,368
+104,384
| +30% | +$6.24M |
2014 Q1
2 quarters
|
|
9
American Tower
AMT
$84.8B
| $27.3M | 2.47% |
291,157
+31,345
| +12% | +$2.98M |
2013 Q2
5 quarters
|
|
|
ESRX
10
DELISTED
Express Scripts Holding Company
ESRX
| $27.2M | 2.47% |
385,411
+67,270
| +21% | +$4.79M |
2013 Q3
4 quarters
|
|
11
Accenture
ACN
$143B
| $27M | 2.46% |
332,575
+62,290
| +23% | +$4.99M |
2013 Q2
5 quarters
|
|
12
Qualcomm
QCOM
$186B
| $27M | 2.45% |
360,484
+39,105
| +12% | +$2.99M |
2013 Q2
5 quarters
|
|
13
EOG Resources
EOG
$82.5B
| $26.7M | 2.43% |
269,956
+24,600
| +10% | +$2.67M |
2013 Q2
5 quarters
|
|
14
DELISTED
Praxair Inc
PX
| $26.4M | 2.4% |
204,525
+40,960
| +25% | +$5.37M |
2013 Q2
5 quarters
|
|
15
Colgate-Palmolive
CL
$74.3B
| $26.3M | 2.39% |
403,584
+77,260
| +24% | +$5.1M |
2013 Q2
5 quarters
|
|
|
PCP
16
DELISTED
PRECISION CASTPARTS CORP
PCP
| $26.2M | 2.38% |
110,710
+25,095
| +29% | +$6.09M |
2013 Q2
5 quarters
|
|
17
Nike
NKE
$55B
| $25.7M | 2.33% |
575,726
+83,910
| +17% | +$3.33M |
2013 Q2
5 quarters
|
|
18
BioMarin Pharmaceuticals
BMRN
$10.6B
| $25.3M | 2.3% |
350,895
+75,710
| +28% | +$4.98M |
2014 Q1
2 quarters
|
|
19
Akamai
AKAM
$12.7B
| $23.2M | 2.11% |
387,865
+100,150
| +35% | +$6.02M |
2013 Q4
3 quarters
|
|
20
Gilead Sciences
GILD
$192B
| $22.8M | 2.07% |
214,144
+15,680
| +8% | +$1.54M |
2013 Q2
5 quarters
|
|
21
Amphenol
APH
$200B
| $22.5M | 2.04% |
3,604,800
+452,640
| +14% | +$2.84M |
2013 Q2
5 quarters
|
|
22
Cummins
CMI
$72.4B
| $20.8M | 1.89% |
157,588
+33,765
| +27% | +$4.87M |
2013 Q2
5 quarters
|
|
23
FMC
FMC
$821M
| $20.1M | 1.82% |
404,280
+58,106
| +17% | +$3.3M |
2013 Q2
5 quarters
|
|
|
24
Cooper Companies
COO
$11B
| $19.2M | 1.75% |
+494,040
| New | +$19.4M |
2014 Q3
0 quarters
|
|
|
25
Blackrock
BLK
$175B
| $19M | 1.73% |
+57,882
| New | +$18.6M |
2014 Q3
0 quarters
|
|
Similar funds
CC
Robert Torray's Q3 2014 Portfolio in Review
As of Q3 2014, Robert Torray held 94 positions worth $1.1B, up 12% from $987M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Robert Torray deployed $121M of net new capital in Q3 2014, opening 3 new positions and adding to 32 existing holdings. Its largest new stake was Cooper Companies: 494,040 shares worth $19.2M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Republic Services, an estimated $3.16M trimmed.
- Robert Torray's largest Q3 2014 buy was Cooper Companies: 494,040 shares worth $19.2M.
- Robert Torray added most to Baxter International in Q3 2014, an estimated $7.37M increase.
- Robert Torray's biggest Q3 2014 reduction was Republic Services, cutting an estimated $3.16M.
- Robert Torray fully exited Franklin Templeton in Q3 2014, selling an estimated $20M.
- Robert Torray's ten largest holdings make up 28% of its $1.1B portfolio in Q3 2014.
- Robert Torray opened 3 new positions and closed 6 in Q3 2014.
- Robert Torray's portfolio value rose 12% quarter-over-quarter to $1.1B.
Based on Torray Investment Partners's 13F filing for Q3 2014, filed 27 Oct 2014.